Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review
Pouria Shoureshi1, Alex Y Tan1, Jayanthi Koneru2
1Virginia Commonwealth University/Pauley Heart Center, Richmond, Virginia, USA; Central Virginia Veterans Affair Health Care System, Richmond, Virginia, USA.
Insights
Arrhythmia-induced cardiomyopathy (AiCM) is a reversible condition caused by heart rhythm problems. Early diagnosis and treatment of these arrhythmias can restore heart function and improve patient outcomes.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Research
Background:
- Arrhythmias, including tachycardias, atrial fibrillation, and premature ventricular contractions, are common in heart failure.
- These arrhythmias can lead to a reversible form of dilated cardiomyopathy, termed arrhythmia-induced cardiomyopathy (AiCM).
- Individual susceptibility to AiCM despite similar arrhythmia burdens remains an area of investigation.
Purpose of the Study:
- To explore the relationship between arrhythmias and left ventricular dysfunction.
- To identify key indicators for considering AiCM in clinical practice.
- To outline diagnostic and therapeutic strategies for AiCM.
Main Methods:
- Clinical observation and diagnosis of patients with heart failure and arrhythmias.
- Assessment of left ventricular function and response to arrhythmia elimination.
- Evaluation of patient comorbidities and preferences for guiding therapy.
Main Results:
- AiCM is a significant cause of reversible left ventricular dysfunction.
- Specific criteria (mean heart rate >100 bpm, atrial fibrillation, or PVC burden >10%) suggest AiCM.
- Reversal of cardiomyopathy is confirmed by the elimination of the causative arrhythmia.
Conclusions:
- Accurate diagnosis and treatment of AiCM can significantly improve patient quality of life and clinical outcomes.
- Effective management of AiCM can reduce hospital admissions and healthcare costs.
- Ongoing monitoring is crucial for patients with persistent myocardial abnormalities after functional recovery.
Abstract:
Arrhythmias frequently accompany heart failure and left ventricular dysfunction. Tachycardias, atrial fibrillation, and premature ventricular contractions can induce a reversible form of dilated cardiomyopathy (CM) known as arrhythmia-induced CM (AiCM). The intriguing question is why certain individuals are more susceptible to AiCM, despite similar arrhythmia burdens. The primary challenge is determining the extent of arrhythmias' contribution to left ventricular systolic dysfunction. AiCM should be considered in patients with a mean heart rate of >100 beats/min, atrial fibrillation, or a PVC burden of >10%. Confirmation of AiCM occurs when CM reverses upon eliminating the responsible arrhythmia. Therapy choice depends on the specific arrhythmia, patient comorbidities, and preferences. After left ventricular function is restored, ongoing follow-up is essential if an abnormal myocardial substrate persists. Accurate diagnosis and treatment of AiCM have the potential to enhance patients' quality of life, improve clinical outcomes, and reduce hospital admissions and overall health care costs.
More Related Videos
12:15Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease
Published on: February 8, 2022
08:31Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction
Published on: July 26, 2018
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Electrophysiology of Normal Cardiac Rhythm
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Pathophysiology of Cardiac Performance
Pathophysiology of Heart Failure
